Grossi Federico 4
4 · Apellis Pharmaceuticals, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-02-23−4,100→ 57,723 totalExercise: $4.31Exp: 2027-08-20→ Common Stock (4,100 underlying) - Exercise/Conversion
Common Stock
2022-02-23$4.31/sh+4,100$17,671→ 110,186 total
Footnotes (1)
- [F1]This stock option was granted on 08/21/2017 and is fully vested.